News

MHRA consult over naproxen from POM to P

13-Apr-07

The Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on changing the classification of naproxen 250mg from a prescription only medicine to pharmacy only.

Dysmenorrhoea (period pain) is a common, chronic, recurring condition, which affects a significant proportion of women of reproductive age. Many of these women rely on OTC analgesics to manage this pain.

Dysmenorrhoea responds well to treatment with non-steroidal anti-inflammatory drugs (NSAIDs) because these products inhibit the production of prostaglandins which play a part in the smooth muscle contractility of the womb.

Currently, ibuprofen is the only available non-prescription NSAID.

The MHRA believes that naproxen would be a good alternative to ibuprofen and pharmacists have demonstrated their ability to recommend OTC treatments for dysmenorrhoea.

The consultation documents may be found on the MHRA website

MIMS links
Printable patient fact sheet on dysmenorrhoea

Dysmenorrhoea

Pain and fever

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Supporting victims of childhood sexual abuse

Health professionals can help patients recover from psychosexual trauma, writes Graham Wilmer. Read More

Rise of the GP-led health centres

As the new 'super-surgeries' open, we consider the possible opportunities for nurses. Joe Lepper rep... Read More

Career Profile - Staff nurse, eating disorders service

Daniel Brown, Roehampton, London Read More

Show all articles

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more

Jobs

 

Job of the Week